Abstract
In this study, we applied “Bakumon-do-to” to 26 patients with dry mouth. The patients included 4 with Sjogren syndrome but none with radiation induced xerostomia. In the 22 patients without Sjogren syndrome, 17 were administered drugs to reduce saliva. After treatment, the subjective symptoms were improved in 19 of the 26 patients (73%) and objective findings were improved in 14 of the 26 patients (54%). In addition, the volumes of unstimulated whole saliva were significantly increased (mean value of increase: 0.04±0.03ml/min) (p>0.05).Most of the improvement in subjective and objective symptoms could be observed within 6 weeks. The efficacy was also investigated with reference to the age, gender, systemic medications and salivary gland funcution. There were no differences in age and gender between the subjectively improved and not improved groups. The efficacy was not affected by the difference in systemic medications and degree of salivary dysfunction.
